The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy

  1. Fernández-Juárez, G.
  2. Rojas-Rivera, J.
  3. Logt, A.-E.V.D.
  4. Justino, J.
  5. Sevillano, A.
  6. Caravaca-Fontán, F.
  7. Ávila, A.
  8. Rabasco, C.
  9. Cabello, V.
  10. Varela, A.
  11. Díez, M.
  12. Martín-Reyes, G.
  13. Diezhandino, M.G.
  14. Quintana, L.F.
  15. Agraz, I.
  16. Gómez-Martino, J.R.
  17. Cao, M.
  18. Rodríguez-Moreno, A.
  19. Rivas, B.
  20. Galeano, C.
  21. Bonet, J.
  22. Romera, A.
  23. Shabaka, A.
  24. Plaisier, E.
  25. Espinosa, M.
  26. Egido, J.
  27. Segarra, A.
  28. Lambeau, G.
  29. Ronco, P.
  30. Wetzels, J.
  31. Praga, M.
  32. Trujillo, H.
  33. Gutiérrez, E.
  34. Juarez, G.F.
  35. Ortiz, A.
  36. Goicoechea, M.
  37. Verdalles, Ú.
  38. Segarra, A.
  39. Perea, L.
  40. Valera, I.
  41. Martín, M.
  42. Pérez Valdivia, M.A.
  43. Blasco, M.
  44. Muñiz, A.L.
  45. Avila, A.
  46. Malek, T.
  47. Diaz, M.
  48. DaSilva, I.
  49. Bonet, J.
  50. Navarro, M.
  51. Huerta, A.
  52. Rodríguez-Paternina, E.
  53. Vigil, A.
  54. Alcázar, R.
  55. Paraíso, V.
  56. Barrio, V.
  57. Hofstra, J.
  58. Show all authors +
Journal:
Kidney International

ISSN: 1523-1755 0085-2538

Year of publication: 2021

Volume: 99

Issue: 4

Pages: 986-998

Type: Article

DOI: 10.1016/J.KINT.2020.10.014 GOOGLE SCHOLAR lock_openOpen access editor